Stock Report

All about this stock under one free report Last Updated: 28-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

BiondVax Pharmaceuticals - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.69

up-down-arrow $0.05 (7.81%)

As on 08-Nov-2023 09:30EDT

Market cap

info icon

$5 Mln

Revenue (TTM)

info icon

$2 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

7.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -26.64 -- --
EBIT 59.65 74.57 62.64 23.71 9.54
Net Profit -167.21 68.84 141.72 28.40 18.66
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-22Dec-21
EBIT-Margin info -1,267.43-1,267.43-618.44---1,267.43
Net Margin info ----854.38----
Return on equity info -188.41-64.78---4.92-540.71
Return on Capital info -25.77-54.60---0.94-92.87
Return on Assets info -25.75-58.4526.32-0.84-86.63
Debt to Equity (x) info -----3.28-12.242.99

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
--
-0.94
-92.87
16.51
-162.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
--
-4.92
-540.71
-19.59
338.45
Peer Median
-40.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

26.32

Higher than Peers by 57.16

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
26.32
-0.84
-86.63
10.21
-172.56
Peer Median
-30.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-618.44

Lower than Peers by 536.23

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
-618.44
--
-1,267.43
--
--
Peer Median
-82.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

854.38

Higher than Peers by 944.26

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
854.38
--
-1,848.98
--
--
Peer Median
-89.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Higher than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-26.64

Lower than Peers by 80.67

Year on year growth in net sales

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
-26.64
-1.00
--
--
--
Peer Median
54.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

62.64

Higher than Peers by 63.60

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
62.64
68.24
-3,449.19
101.33
-292.87
Peer Median
-0.95
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

141.72

Higher than Peers by 148.90

Year on year growth in profit after tax

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
141.72
98.95
-845.54
105.49
-432.82
Peer Median
-7.19
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

-3.28

--

Total debt / Net worth

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
-3.28
-12.24
2.99
-4.60
-2.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-0.06

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
-0.06
-0.22
0.03
-4.18
-0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

4.12

Lower than Peers by 1.69

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
4.12
6.15
7.64
0.17
3.86
Peer Median
5.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

4.12

Lower than Peers by 1.58

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
4.12
--
--
--
--
Peer Median
5.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

0.93

Higher than Peers by 3.02

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
0.93
-2.10
-3.22
0.21
-5.25
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

6.85

Lower than Peers by 12.13

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
6.85
--
11.14
--
--
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.03

Lower than Peers by 0.04

Sales / Average Total Assets

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
0.03
--
0.05
--
--
Peer Median
0.07
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
--
--
45.22
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Book Value

7.48

Higher than Peers by 2.13

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
7.48
--
--
--
--
Peer Median
5.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-2.07

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
-2.07
-0.71
-0.48
5.17
-0.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

5

Lower than Peers by 142

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-22
Dec-21
Dec-20
Dec-19
BiondVax Pharmaceuticals - ADR
5
--
--
--
--
Peer Median
147
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...